pI: 8.2171 |
Length (AA): 590 |
MW (Da): 69642 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
106 | 486 | 1cs8 (A) | 3 | 219 | 20.00 | 0 | 1 | 0.7 | 0.4 |
161 | 191 | 2eof (A) | 8 | 38 | 19.00 | 0.93 | 0.02 | 0.382142 | -1.67 |
226 | 570 | 2c0y (A) | 11 | 313 | 27.00 | 0.00000015 | 1 | 0.502346 | 0.85 |
499 | 560 | 3u8e (A) | 161 | 202 | 48.00 | 0.01 | 0.58 | 0.101685 | 0.64 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | gametocyte, Female Gametocyte, Male Gametocyte. | PlasmoDB Lasonder E |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | merozoite, sporozoite, late schizont. | PlasmoDB |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | intra-erythrocytic - 16 hs, intra-erythrocytic - 40 hs, intra-erythrocytic - 48 hs, Oocyst, Ring, Sporozoite. | Otto TD Zanghi G |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | intra-erythrocytic - 0 hs, intra-erythrocytic - 8 hs, intra-erythrocytic - 24 hs, intra-erythrocytic - 32 hs, early schizont, late trophozoite. | Otto TD PlasmoDB |
Zanghi G | A Specific PfEMP1 Is Expressed in P. falciparum Sporozoites and Plays a Role in Hepatocyte Infection. |
PlasmoDB | Data on upregulation of P. falciparum genes in different life cycle stages, combined from several microarray experiments available in PlasmoDB |
Otto TD | New insights into the blood-stage transcriptome of Plasmodium falciparum using RNA-Seq. |
Lasonder E | Integrated transcriptomic and proteomic analyses of P. falciparum gametocytes. Molecular insight into sex-specific processes and translational repression. |
Ortholog group members (OG5_130494)
Species | Accession | Gene Product |
---|---|---|
Babesia bovis | BBOV_I000540 | preprocathepsin c precursor, putative |
Babesia bovis | BBOV_II000170 | cathepsin C precursor, putative |
Caenorhabditis elegans | CELE_F36D3.9 | Protein CPR-2 |
Cryptosporidium hominis | Chro.40239 | preprocathepsin c precursor |
Cryptosporidium parvum | cgd4_2110 | preprocathepsin c precursor, putative |
Dictyostelium discoideum | DDB_G0292462 | hypothetical protein |
Giardia lamblia | GL50803_14566 | Dipeptidyl-peptidase I precursor |
Homo sapiens | ENSG00000109861 | cathepsin C |
Mus musculus | ENSMUSG00000030560 | cathepsin C |
Neospora caninum | NCLIV_041870 | hypothetical protein |
Plasmodium berghei | PBANKA_1460700 | dipeptidyl aminopeptidase 2 |
Plasmodium berghei | PBANKA_0931300 | dipeptidyl aminopeptidase 1, putative |
Plasmodium falciparum | PF3D7_1116700 | dipeptidyl aminopeptidase 1 |
Plasmodium falciparum | PF3D7_1247800 | dipeptidyl aminopeptidase 2 |
Plasmodium knowlesi | PKNH_1467500 | dipeptidyl aminopeptidase 2, putative |
Plasmodium knowlesi | PKNH_0914400 | dipeptidyl aminopeptidase 1, putative |
Plasmodium vivax | PVX_091465 | dipeptidyl aminopeptidase 1, putative |
Plasmodium vivax | PVX_101280 | dipeptidyl aminopeptidase 2, putative |
Plasmodium yoelii | PY02150 | Homo sapiens P3ECSL-related |
Plasmodium yoelii | PY05365 | cathepsin c precursor |
Schistosoma japonicum | Sjp_0207730 | Cathepsin C precursor, putative |
Schistosoma japonicum | Sjp_0207740 | ko:K01275 cathepsin C [EC3.4.14.1], putative |
Schistosoma mansoni | Smp_019030 | dipeptidyl-peptidase I (C01 family) |
Schmidtea mediterranea | mk4.002926.00 | Dipeptidyl peptidase 1 |
Schmidtea mediterranea | mk4.002926.03 | Dipeptidyl peptidase 1 |
Toxoplasma gondii | TGME49_289620 | cathepsin CPC1 |
Toxoplasma gondii | TGME49_267490 | preprocathepsin c precursor, putative |
Theileria parva | TP02_0883 | cathepsin C, putative |
Theileria parva | TP03_0357 | cathepsin C, putative |
Trichomonas vaginalis | TVAG_159150 | Clan CA, family C1, cathepsin B-like cysteine peptidase |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
PBANKA_0931300 | Plasmodium berghei | Essential | plasmo |
PBANKA_1460700 | Plasmodium berghei | Dispensable | plasmo |
TGME49_289620 | Toxoplasma gondii | Probably non-essential | sidik |
TGME49_267490 | Toxoplasma gondii | Probably non-essential | sidik |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.6
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Infectious bronchitis virus | 3C-like protease | Compounds | References |
Homo sapiens | cathepsin C | Compounds | References |
Mus musculus | cathepsin C | Compounds | References |
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Bos taurus | Cathepsin L | 334 aa | 24.8% | 298 aa | Compounds | References |
Bos taurus | Cathepsin B | 335 aa | 23.7% | 312 aa | Compounds | References |
Oryctolagus cuniculus | Cathepsin K | 329 aa | 27.1% | 269 aa | Compounds | References |
Capra hircus | Cathepsin B | 335 aa | 26.5% | 302 aa | Compounds | References |
Leishmania major | cysteine peptidase C (CPC),CPC cysteine peptidase, Clan CA, family C1, Cathepsin B-like | 340 aa | 22.6% | 328 aa | Compounds | References |
Rattus norvegicus | Cathepsin K | 329 aa | 26.5% | 268 aa | Compounds | References |
Schistosoma mansoni | cathepsin B-like peptidase (C01 family) | 340 aa | 23.6% | 275 aa | Compounds | References |
Trypanosoma cruzi | major cysteine proteinase, putative | 247 aa | 19.9% | 221 aa | Compounds | References |
Capra hircus | Cathepsin H | 335 aa | 25.7% | 269 aa | Compounds | References |
Trypanosoma brucei | cysteine peptidase C (CPC) | 340 aa | 21.9% | 292 aa | Compounds | References |
Rattus norvegicus | Cathepsin B | 339 aa | 27.3% | 300 aa | Compounds | References |
Rattus norvegicus | Cathepsin S | 330 aa | 23.0% | 283 aa | Compounds | References |
Rattus norvegicus | Cathepsin L | 334 aa | 23.8% | 294 aa | Compounds | References |
Target | Type | Source | Notes |
---|---|---|---|
PF3D7_1247800 | purified protein | BRENDA | A protein with this EC number or name or sequence has been purified from Plasmodium falciparum ( 1 ) |
1 literature reference was collected for this gene.